Žaidimo vietos santrauka
| States | Namų rungtynės | Išvykos rungtynės |
|---|---|---|
| MIN | 10:00 | 29:00 |
| 2P M/A |
50%
2/4
|
100%
2/2
|
| 3P M/A |
100%
1/1
|
33.3%
1/3
|
| FT M/A |
100%
1/1
|
66.7%
4/6
|
| REB |
4
2/2
|
4
2/2
|
| AS | 1 | 2 |
| ST | 0 | 2 |
| TO | 3 | 0 |
| BS | 1 | 0 |
| PF | 3 | 6 |
| PTS | 8 | 11 |
| EFF | 9 | 15 |
| GM | 1 | 2 |
| States | Namų rungtynės | Išvykos rungtynės |
|---|---|---|
| MIN | 10:00 | 14:30 |
| 2P M/A |
50%
2/4
|
100%
2/2
|
| 3P M/A |
100%
1/1
|
33.3%
1/3
|
| FT M/A |
100%
1/1
|
66.7%
4/6
|
| REB |
4
2/2
|
2
1/1
|
| AS | 1 | 1 |
| ST | 0 | 1 |
| TO | 3 | 0 |
| BS | 1 | 0 |
| PF | 3 | 3 |
| PTS | 8 | 5.5 |
| EFF | 9 | 7.5 |
| GM | 1 | 2 |
Žaidimo rezultatų santrauka
| States | Pralaimėjimai |
|---|---|
| MIN | 39:00 |
| 2P M/A |
66.7%
4/6
|
| 3P M/A |
50%
2/4
|
| FT M/A |
71.4%
5/7
|
| REB |
8
4/4
|
| AS | 3 |
| ST | 2 |
| TO | 3 |
| BS | 1 |
| PF | 9 |
| PTS | 19 |
| EFF | 24 |
| GM | 3 |
| States | Pralaimėjimai |
|---|---|
| MIN | 13:00 |
| 2P M/A |
66.7%
4/6
|
| 3P M/A |
50%
2/4
|
| FT M/A |
71.4%
5/7
|
| REB |
2.7
1.3/1.3
|
| AS | 1 |
| ST | 0.7 |
| TO | 1 |
| BS | 0.3 |
| PF | 3 |
| PTS | 6.3 |
| EFF | 8 |
| GM | 3 |
Naujausi žaidimo rezultatai
| States | Paskutinės 5 rungtynės | Last 10 games |
|---|---|---|
| MIN | 39:00 | 39:00 |
| 2P M/A |
66.7%
4/6
|
66.7%
4/6
|
| 3P M/A |
50%
2/4
|
50%
2/4
|
| FT M/A |
71.4%
5/7
|
71.4%
5/7
|
| REB |
8
4/4
|
8
4/4
|
| AS | 3 | 3 |
| ST | 2 | 2 |
| TO | 3 | 3 |
| BS | 1 | 1 |
| PF | 9 | 9 |
| PTS | 19 | 19 |
| EFF | 24 | 24 |
| GM | 3 | 3 |
| States | Paskutinės 5 rungtynės | Last 10 games |
|---|---|---|
| MIN | 13:00 | 13:00 |
| 2P M/A |
66.7%
4/6
|
66.7%
4/6
|
| 3P M/A |
50%
2/4
|
50%
2/4
|
| FT M/A |
71.4%
5/7
|
71.4%
5/7
|
| REB |
2.7
1.3/1.3
|
2.7
1.3/1.3
|
| AS | 1 | 1 |
| ST | 0.7 | 0.7 |
| TO | 1 | 1 |
| BS | 0.3 | 0.3 |
| PF | 3 | 3 |
| PTS | 6.3 | 6.3 |
| EFF | 8 | 8 |
| GM | 3 | 3 |
Mėnesinė ir priešininkų analizė
| States | Suminiai | Rugsėjis |
|---|---|---|
| MIN | 39:00 | 39:00 |
| 2P M/A |
66.7%
4/6
|
66.7%
4/6
|
| 3P M/A |
50%
2/4
|
50%
2/4
|
| FT M/A |
71.4%
5/7
|
71.4%
5/7
|
| REB |
8
4/4
|
8
4/4
|
| AS | 3 | 3 |
| ST | 2 | 2 |
| TO | 3 | 3 |
| BS | 1 | 1 |
| PF | 9 | 9 |
| PTS | 19 | 19 |
| EFF | 24 | 24 |
| GM | 3 | 3 |
| States | Suminiai | Rugsėjis |
|---|---|---|
| MIN | 13:00 | 13:00 |
| 2P M/A |
66.7%
4/6
|
66.7%
4/6
|
| 3P M/A |
50%
2/4
|
50%
2/4
|
| FT M/A |
71.4%
5/7
|
71.4%
5/7
|
| REB |
2.7
1.3/1.3
|
2.7
1.3/1.3
|
| AS | 1 | 1 |
| ST | 0.7 | 0.7 |
| TO | 1 | 1 |
| BS | 0.3 | 0.3 |
| PF | 3 | 3 |
| PTS | 6.3 | 6.3 |
| EFF | 8 | 8 |
| GM | 3 | 3 |
| States | Suminiai | Tianjin Pioneers |
|---|---|---|
| MIN | 39:00 | 10:00 |
| 2P M/A |
66.7%
4/6
|
50%
2/4
|
| 3P M/A |
50%
2/4
|
100%
1/1
|
| FT M/A |
71.4%
5/7
|
100%
1/1
|
| REB |
8
4/4
|
4
2/2
|
| AS | 3 | 1 |
| ST | 2 | 0 |
| TO | 3 | 3 |
| BS | 1 | 1 |
| PF | 9 | 3 |
| PTS | 19 | 8 |
| EFF | 24 | 9 |
| GM | 3 | 1 |
| States | Suminiai | Tianjin Pioneers |
|---|---|---|
| MIN | 13:00 | 10:00 |
| 2P M/A |
66.7%
4/6
|
50%
2/4
|
| 3P M/A |
50%
2/4
|
100%
1/1
|
| FT M/A |
71.4%
5/7
|
100%
1/1
|
| REB |
2.7
1.3/1.3
|
4
2/2
|
| AS | 1 | 1 |
| ST | 0.7 | 0 |
| TO | 1 | 3 |
| BS | 0.3 | 1 |
| PF | 3 | 3 |
| PTS | 6.3 | 8 |
| EFF | 8 | 9 |
| GM | 3 | 1 |
| States | Suminiai | Shandong Hi-Speed |
|---|---|---|
| MIN | 39:00 | 20:00 |
| 2P M/A |
66.7%
4/6
|
100%
1/1
|
| 3P M/A |
50%
2/4
|
50%
1/2
|
| FT M/A |
71.4%
5/7
|
100%
1/1
|
| REB |
8
4/4
|
2
1/1
|
| AS | 3 | 2 |
| ST | 2 | 1 |
| TO | 3 | 0 |
| BS | 1 | 0 |
| PF | 9 | 2 |
| PTS | 19 | 6 |
| EFF | 24 | 10 |
| GM | 3 | 1 |
| States | Suminiai | Shandong Hi-Speed |
|---|---|---|
| MIN | 13:00 | 20:00 |
| 2P M/A |
66.7%
4/6
|
100%
1/1
|
| 3P M/A |
50%
2/4
|
50%
1/2
|
| FT M/A |
71.4%
5/7
|
100%
1/1
|
| REB |
2.7
1.3/1.3
|
2
1/1
|
| AS | 1 | 2 |
| ST | 0.7 | 1 |
| TO | 1 | 0 |
| BS | 0.3 | 0 |
| PF | 3 | 2 |
| PTS | 6.3 | 6 |
| EFF | 8 | 10 |
| GM | 3 | 1 |
| States | Suminiai | Qingdao Guoxin Pharmaceutical |
|---|---|---|
| MIN | 39:00 | 9:00 |
| 2P M/A |
66.7%
4/6
|
100%
1/1
|
| 3P M/A |
50%
2/4
|
0%
0/1
|
| FT M/A |
71.4%
5/7
|
60%
3/5
|
| REB |
8
4/4
|
2
1/1
|
| AS | 3 | 0 |
| ST | 2 | 1 |
| TO | 3 | 0 |
| BS | 1 | 0 |
| PF | 9 | 4 |
| PTS | 19 | 5 |
| EFF | 24 | 5 |
| GM | 3 | 1 |
| States | Suminiai | Qingdao Guoxin Pharmaceutical |
|---|---|---|
| MIN | 13:00 | 9:00 |
| 2P M/A |
66.7%
4/6
|
100%
1/1
|
| 3P M/A |
50%
2/4
|
0%
0/1
|
| FT M/A |
71.4%
5/7
|
60%
3/5
|
| REB |
2.7
1.3/1.3
|
2
1/1
|
| AS | 1 | 0 |
| ST | 0.7 | 1 |
| TO | 1 | 0 |
| BS | 0.3 | 0 |
| PF | 3 | 4 |
| PTS | 6.3 | 5 |
| EFF | 8 | 5 |
| GM | 3 | 1 |